09.13.11
DaVita Clinical Research (DCR) has added biorepository services, offering the pharmaceutical industry collaborative research opportunities that combine access to high-quality samples with well-characterized patient data annotation.
DCR’s biorepository provides customized sample sets from patient populations collected nationally. These samples are collected under an IRB-approved protocol with the consent of patients. The samples contain high RNA and DNA yields and are suitable for genomic analysis. DCR also collects samples for proteomic and metabolomic testing.
“We are excited to begin this new chapter and believe the biorepository we are creating will set a new standard in the industry and add value to the drug discovery efforts of our partners,” said DCR president Chris Rucker. “We believe that the unique characteristics of our offering will position us to meet a need in the discovery community that is currently not being satisfied by the existing biorepositories.”
DCR’s biorepository provides customized sample sets from patient populations collected nationally. These samples are collected under an IRB-approved protocol with the consent of patients. The samples contain high RNA and DNA yields and are suitable for genomic analysis. DCR also collects samples for proteomic and metabolomic testing.
“We are excited to begin this new chapter and believe the biorepository we are creating will set a new standard in the industry and add value to the drug discovery efforts of our partners,” said DCR president Chris Rucker. “We believe that the unique characteristics of our offering will position us to meet a need in the discovery community that is currently not being satisfied by the existing biorepositories.”